Article Details

Struggling bluebird bio to go private for less than $30m - Pharmaceutical Technology

Retrieved on: 2025-02-21 17:24:46

Tags for this article:

Click the tags to see associated articles and topics

Struggling bluebird bio to go private for less than $30m - Pharmaceutical Technology. View article details on hiswai:

Excerpt

Bluebird bio has found a new nest with Carlyle and SK Capital. ... Vertex Pharmaceuticals' Casgevy, for example, is priced at $2.2m per ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up